Michael Moxness

Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics

Marisa K. Joubert, Meghana Deshpande, Jane Yang et al. · PLoS ONE · 2016 · 114 citations · Full text

Life Sciences, Immunology, Cellular Immunology +16

Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys

David N. Hovland, Robert B. Boyd, Mark T. Butt et al. · Toxicologic Pathology · 2007 · 108 citations

Life Sciences, Neuroscience, Pharmacology +17

Terminal and new bridging coordination of methylguanidine, arginine, and canavanine to platinum(II). The first crystallographic study of bonding between a transition metal and a guanidine ligand

Eva Marie A. Ratilla, Brian K. Scott, Michael Moxness et al. · Inorganic Chemistry · 1990 · 94 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal Antibodies

Michael Moxness, Suzanna Tatarewicz, Dohan Weeraratne et al. · Clinical Chemistry · 2005 · 80 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab

Primal Kaur, Vincent Chow, Nan Zhang et al. · Annals of the Rheumatic Diseases · 2016 · 78 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16